UBS ASSET MANAGEMENT AMERICAS LLC - SYNTA PHARMACEUTICALS CORP ownership

SYNTA PHARMACEUTICALS CORP's ticker is SNTA and the CUSIP is 87162T206. A total of 97 filers reported holding SYNTA PHARMACEUTICALS CORP in Q2 2015. The put-call ratio across all filers is 1.33 and the average weighting 0.8%.

Quarter-by-quarter ownership
UBS ASSET MANAGEMENT AMERICAS LLC ownership history of SYNTA PHARMACEUTICALS CORP
ValueSharesWeighting
Q1 2016$7,000
-36.4%
31,098
-4.0%
0.00%
Q4 2015$11,000
-80.4%
32,3770.0%0.00%
Q3 2015$56,000
-22.2%
32,3770.0%0.00%
Q2 2015$72,000
+28.6%
32,377
+11.3%
0.00%
Q1 2015$56,000
-15.2%
29,077
+16.4%
0.00%
Q4 2014$66,000
-12.0%
24,9770.0%0.00%
Q3 2014$75,000
-26.5%
24,9770.0%0.00%
Q2 2014$102,000
-5.6%
24,9770.0%0.00%
Q1 2014$108,000
-17.6%
24,9770.0%0.00%
Q4 2013$131,000
-3.7%
24,977
+15.8%
0.00%
Q3 2013$136,000
+25.9%
21,5770.0%0.00%
Q2 2013$108,00021,5770.00%
Other shareholders
SYNTA PHARMACEUTICALS CORP shareholders Q2 2015
NameSharesValueWeighting ↓
CAXTON CORP 37,069,140$64,500,00087.00%
ARMISTICE CAPITAL, LLC 2,000,000$3,480,0001.19%
IRONWOOD INVESTMENT MANAGEMENT LLC 432,259$752,0000.28%
Geller Advisors LLC 187,323$326,0000.21%
CAXTON CORP 57,000$99,0000.13%
Verity Asset Management, Inc. 64,476$112,0000.11%
TFS CAPITAL LLC 367,364$639,0000.06%
Cutler Capital Management, LLC 72,500$126,0000.06%
LUCAS CAPITAL MANAGEMENT 21,100$37,0000.02%
Nine Chapters Capital Management LLC 129,700$226,0000.02%
View complete list of SYNTA PHARMACEUTICALS CORP shareholders